Disclosures for "Analysis of Local Treatment-emergent Adverse Events in Patients With CIDP Treated With fSCIG During the ADVANCE-CIDP1 and Long-term ADVANCE-CIDP3 Trials "
-
Dr. Ajibade has received personal compensation for serving as an employee of Takeda. Dr. Ajibade has or had stock in Takeda.
-
Dr. Riaz has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Riaz has stock in Takeda.
-
Dr. Lamarre has nothing to disclose.
-
Dr. Nero has received personal compensation for serving as an employee of Takeda Pharmaceuticals . Dr. Nero has received personal compensation for serving as an employee of Daiichi Sankyo. Dr. Nero has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG.
-
Mrs. Duff has stock in Takeda Pharmaceuticals .
-
Dr. Greco has nothing to disclose.
-
Miss Garcia has nothing to disclose.
-
Dr. AY has received personal compensation for serving as an employee of Takeda.